Caitlin Raymond on ”The Plasma Chasers”
Caitlin Raymond, Assistant Professor of Pathology and Transfusion Medicine at University of Wisconsin-Madison, shared on LinkedIn:
”I wrote a new piece this week about something I hadn’t encountered until I became an attending: the “plasma chaser.”
It’s not in ASFA guidelines, not in textbooks, and not something I ever saw in residency or fellowship. But it came up twice in two days, and it made me pause and think about how we make replacement-fluid decisions after recent procedures — and how much of that work happens in the gray space where physiology, experience, and uncertainty meet.
What I found, digging into the peer-reviewed survey data, is striking:
- 8.9% of clinicians still use albumin-only replacement one day after major surgery, a number much higher than I was expecting.
- Clinicians are split about 50/50 on using albumin vs plasma for replacement fluid a day following a minor procedure.
- For a patient scenario with no bleeding risk, 5.3% of clinicians will still use plasma, also higher than I was expecting.
There’s a story in those numbers — about risk perception, about judgment, and about how small, experience-driven practices evolve when formal guidance is limited.
In my blog post, I tried to unpack this… not to prescribe a standard, but to explore how we think through these nuanced decisions and why certain rituals persist in medicine. And also where a rational, physiologic framework can help us cut through the uncertainty.
If you’re interested in the intersection of transfusion medicine, clinical reasoning, and the quiet rituals we inherit in practice, you can read the full piece here.
Would love to hear how others approach post-procedure TPE decisions in their practice — especially where your institution aligns with (or diverges from) the survey data.”

Stay updated with Hemostasis Today.
-
May 30, 2026, 14:11Monica Verduzco-Gutierrez: A New Spasticity Education and Patient Journey Resource for Stroke Awareness Month Is Now Live
-
May 30, 2026, 13:59Chinua Onyebuchi: Proud to Contribute to The Wider Mission of The British Heart Foundation and The Stroke Association
-
May 30, 2026, 13:52Gerrit M. Grosse: How Integrative Biomarker Approaches May Improve Our Understanding of Brain-Immune Crosstalk After Stroke
-
May 30, 2026, 13:15Highlight Groundbreaking and Emerging Science From the Posters by Leading an ASH Poster Walk at ASH26
-
May 30, 2026, 10:36Saman Adnan: New Research Explores Readmission Risk in Brain Cancer Patients With VTE
-
May 30, 2026, 10:27Sartaj Alam: CBC Analyzer – The Backbone of Modern Hematology Diagnostics
-
May 30, 2026, 10:17Factor X Deficiency – From Mild Bruising to Life Threatening Hemorrhage – ICHCC
-
May 30, 2026, 10:06Johann Morelle: Complement Inhibitors Are Reshaping Modern Nephrology
-
May 30, 2026, 09:49Flora Peyvandi: Exploring a Multidisciplinary Care Model for Hemophilia and Rare Diseases